Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
The use of immune checkpoint inhibitors (ICI) in cancer patients with solid organ allografts is hampered due to potential organ rejection. Here, the authors present a case report of a patient with kidney allograft and show that treatment with the mTOR inhibitor sirolimus preserves peripheral toleran...
Saved in:
Main Authors: | Khashayar Esfahani, Tho-Alfakar Al-Aubodah, Pamela Thebault, Réjean Lapointe, Marie Hudson, Nathalie A. Johnson, Dana Baran, Najwa Bhulaiga, Tomoko Takano, Jean-François Cailhier, Ciriaco A. Piccirillo, Wilson H. Miller |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/7b6d74e8eca445f991f3a9a988480cef |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137+ FOXP3+ Regulatory T Cells Detectable in Peripheral Blood
by: Yi Zhang, et al.
Published: (2021) -
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
by: Yoon MS
Published: (2020) -
The mTOR pathway is necessary for survival of mice with short telomeres
by: Iole Ferrara-Romeo, et al.
Published: (2020) -
mTOR-dependent phosphorylation controls TFEB nuclear export
by: Gennaro Napolitano, et al.
Published: (2018) -
Activity-independent targeting of mTOR to lysosomes in primary osteoclasts
by: Andrew Wang, et al.
Published: (2017)